Discover how Kroll's M&A Advisory and Investigations teams helped a family company sell their business through constructing a robust financial projection model to attract lenders and investors. Request Our Qualifications


Kroll’s Healthcare M&A practice has extensive experience in the healthcare sector, including Healthcare IT, Facilities and Real Estate, Behavioral Health and Rehabilitation, Home Health and Hospice, Pharmaceutical Services, Payor Services, Outsourced Services and Alternative Site and Ancillary Care. Our dedicated team of healthcare professionals successfully advises clients on even the most complex transactions.

Discover how Kroll's M&A Advisory and Investigations teams helped a family company sell their business through constructing a robust financial projection model to attract lenders and investors. Request Our Qualifications


Connect with us on LinkedIn

Kroll Corporate Finance and Restructuring is now on LinkedIn. Connect with us for the latest insights on investment banking, corporate finance, restructuring and insolvency solutions.

Related Team

Connect with us


FEATURED CASE STUDIES

Kroll's Investment Banking Team Advised AQREVA and Doctors' Resource Specialists on Its Sale to UnisLink

Kroll's Transaction Advisory Services Practice Rendered Buy-Side Financial and Tax Due Diligence to Multiplan Corporation on Its Acquisition of Benefit Solutions, LLC

Kroll’s Healthcare Investment Banking Practice Advised LSL Healthcare on its Recapitalization by 5th Century Partners

TRI-AD

Kroll's Healthcare Investment Banking Team Advised Medi-Weightloss Inc. on Its Sale to Audax Private Equity

NXC Imaging

RSA

aterian

TheraOffice

SCR Medical Transportation

Avidity Science

Emindful

The Wellness Network

Community Intervention Services

The Jersey Dental Group

Precision Orthopaedics & Sports Medicine

Xtant Medical

Neon Therapeutics

NN. Inc.

mscripts

Kroll's Investment Banking Team Advised AQREVA and Doctors' Resource Specialists on Its Sale to UnisLink

Kroll's Transaction Advisory Services Practice Rendered Buy-Side Financial and Tax Due Diligence to Multiplan Corporation on Its Acquisition of Benefit Solutions, LLC

Kroll’s Healthcare Investment Banking Practice Advised LSL Healthcare on its Recapitalization by 5th Century Partners

TRI-AD

Kroll's Healthcare Investment Banking Team Advised Medi-Weightloss Inc. on Its Sale to Audax Private Equity

NXC Imaging

RSA

aterian

TheraOffice

SCR Medical Transportation

Avidity Science

Emindful

The Wellness Network

Community Intervention Services

The Jersey Dental Group

Precision Orthopaedics & Sports Medicine

Xtant Medical

Neon Therapeutics

NN. Inc.

mscripts

Explore areas we can helpStay Ahead with Kroll

Aerospace Defense and Government Services (ADG) Investment Banking

Aerospace Defense and Government Services (ADG) Investment Banking

Strategic and financial advisory for Aerospace Defense and Government Services clients worldwide.

Consumer Investment Banking

Consumer Investment Banking

Consumer, Retail, Food and Restaurant expertise for middle-market M&A transactions.

Energy Investment Banking

Energy Investment Banking

Energy and Mining expertise for middle-market M&A transactions.

Industrials Investment Banking

Industrials Investment Banking

Industrials expertise for middle-market M&A transactions.

Business Services Investment Banking

Business Services Investment Banking

Business services expertise for middle-market M&A transactions.

Technology Investment Banking

Technology Investment Banking

Technology expertise for middle-market M&A transactions.

Explore Insights

Brazil Transactions Insights Summer 2023

M&A Updates

Brazil Transactions Insights – Summer 2023

Brazil Transactions Insights – Summer 2023

Sep 04, 2023 Activities in the capital market H1 2023 kept the same level as 2022, with only nine follow-ons totaling BRL 15 bn. Since January 2022, Brazil Capital Markets has no IPO’s.

ESG Global Investor Returns Study

Environmental, Social and Governance

ESG and Global Investor Returns Study

ESG and Global Investor Returns Study

Sep 13, 2023 In our inaugural study, we examined the relationship between historical returns of publicly traded companies and their ESG ratings.

Carla Nunes Interview AIRA Journal

Cost of Capital

Navigating the Uncertainty Around Cost of Capital and Valuation Assumptions

AIRA Journal: Navigating the Uncertainty Around Cost of Capital and Valuation Assumptions

Sep 12, 2023 In this AIRA Journal article, Kroll expert Carla Nunes analyzed the impact of COVID19, geopolitical tensions and high inflation on global financial markets. She also discussed the “higher-for-longer” interest rate environment and the growing specter of bankruptcy and restructuring activity.

Canadian MA Insights Summer 2023

M&A Updates

Canadian M&A Insights – Summer 2023

Canadian M&A Industry Insights – Summer 2023

Aug 31, 2023 Canadian M&A activity has declined in deal volume in 1H 2023 compared to 1H 2022 but has increased in disclosed implied enterprise value (EV) – mostly attributed to a few megadeals that closed during the period.

Return to top